Caribou Biosciences CRBU
NASDAQ CRBU
$1.23 -0.04 (-3.54%)
As of: Oct 1, 2026 · 12:07 PM EDT

Caribou Biosciences (CRBU) Preferred Shares (2021)

Updated

Caribou Biosciences' Preferred Shares was $150.15 million in Q2 2021.

Analysis

Caribou Biosciences (CRBU) Preferred Shares (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Caribou Biosciences 134.61 Mn -381.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 150.15 Mn
API Access

Caribou Biosciences Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=CRBU&period=max&api_key=YOUR_API_KEY